| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/03/2013 | US8524862 Muteins of C5a anaphylatoxin and methods of inhibiting C5a |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524652 Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest |
| 09/03/2013 | US8524241 Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A |
| 09/03/2013 | US8524232 Methods of treatment using taci-immunoglobulin fusion proteins |
| 09/03/2013 | CA2478294C Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 09/03/2013 | CA2245877C Hybrid proteins which form heterodimers |
| 09/03/2013 | CA2241564C Wsx receptor and ligands |
| 08/29/2013 | WO2013126690A1 Modified microbial toxin receptor for delivering agents into cells |
| 08/29/2013 | WO2012121392A8 Azoline compound and azole compound library and method for producing same |
| 08/29/2013 | US20130225794 Reduced fluoride crustacean oil compositions |
| 08/29/2013 | US20130224821 Light-Activated Chimeric Opsins and Methods of Using the Same |
| 08/28/2013 | EP2631297A1 Process, vectors and engineered cell lines for enhanced large-scale transfection |
| 08/28/2013 | EP2631249A2 Fusion protein having factor ix activity |
| 08/28/2013 | EP2630162A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 08/28/2013 | CN103270047A Oprf/i agents and their use in hospitalized and other patients |
| 08/28/2013 | CN103266119A Three-antigen fusion gene vaccine of mycobacterium tuberculosis as well as preparation method and application of three-antigen fusion gene vaccine |
| 08/28/2013 | CN103265637A Recombinant porcine interleukin 4-Fc fusion protein as well as coding gene and expression method thereof |
| 08/28/2013 | CN103265636A Novel peptide with hypoglycemic effect |
| 08/28/2013 | CN103265635A Universal construction method for protein-targeting chimeric molecule compound |
| 08/28/2013 | CN103265634A Application of rice transcription factor Os01g64730 gene |
| 08/28/2013 | CN102046207B Drug fusions and conjugates |
| 08/28/2013 | CN101525387B Recombined long-acting glucagons peptide analogue and preparation method thereof |
| 08/28/2013 | CN101522707B 肌肉生长抑制素拮抗剂 Myostatin antagonists |
| 08/27/2013 | US8518411 Modified TGF-β superfamily protein |
| 08/27/2013 | US8518410 Fusion protein with HIV antigen |
| 08/27/2013 | CA2486918C Novel chimeric cd154 |
| 08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |
| 08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
| 08/22/2013 | WO2013123412A1 Conformation-stabilized trap antigens |
| 08/22/2013 | WO2013122262A1 Virus like particle composition |
| 08/22/2013 | WO2013121296A1 Erythrocyte-binding therapeutics |
| 08/22/2013 | US20130216496 Methods for treating tweak-related conditions |
| 08/22/2013 | US20130216475 Methods and compositions for protein labelling |
| 08/21/2013 | EP2628802A1 Dna vaccine based on b7-1-pe40kdel exotoxin fusion gene and use thereof |
| 08/21/2013 | EP2627674A2 Egfr-based peptides |
| 08/21/2013 | EP2143437B1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2013 | CN103261430A Targeted perhydrolases |
| 08/21/2013 | CN103261231A Chimeric spider silk and uses thereof |
| 08/21/2013 | CN103261217A Soluble pd-1 variants, fusion constructs, and uses thereof |
| 08/21/2013 | CN103255159A Recombinant expression and preparation method of cecropin CAD |
| 08/21/2013 | CN103254317A Anti-CD20 monoclonal antibody-aplysiatoxin conjugate as well as preparation method and application thereof |
| 08/21/2013 | CN103254316A Antimicrobial peptide with drug-resistance bacteria resistance activity and synthesis and application thereof |
| 08/21/2013 | CN103254315A Recombinant TAT-MANF (trans-activator of transcription-mesencephalic astrocyte derived neurotrophic factor) fusion protein and application thereof |
| 08/21/2013 | CN103254314A Application of paddy rice transcription factor Os05g41070 gene |
| 08/21/2013 | CN103254313A Combined CTL antigenic epitope and its application |
| 08/21/2013 | CN103254309A Improved nanobodies TM against tumor necrosis factor-alpha |
| 08/21/2013 | CN102183646B Preparation method of rTpN15-17-47-ELISA for detecting syphilis serum antibody |
| 08/21/2013 | CN102167748B Schistosoma japonicum 23kDa membrane protein big hydrophilic peptide segment fusion protein and application thereof in schistosome infection immune diagnosis |
| 08/21/2013 | CN102167747B Entamoeba histolytica galactose/acetylgalactosamine (Gal/GalNAc) polypeptide fragment, and preparing method and application of polypeptide fragment |
| 08/20/2013 | US8513189 Albumin fusion proteins |
| 08/20/2013 | CA2440358C Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 08/15/2013 | WO2013119903A1 Fusion proteins comprising immunoglobulin constant domain-derived scaffolds |
| 08/15/2013 | WO2013118165A1 Pharmaceutical agents fused with atf for improved bioavailability |
| 08/15/2013 | WO2013006486A9 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 08/15/2013 | US20130211049 Immunotoxin fusion proteins and means for expression thereof |
| 08/15/2013 | US20130211044 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 08/15/2013 | US20130210748 Method and peptide for regulating cellular activity |
| 08/15/2013 | US20130210706 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 08/15/2013 | US20130210705 Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof |
| 08/15/2013 | US20130210116 Composition and methods for the diagnosis and treatment of tumor |
| 08/14/2013 | CN103249433A Bio-functionalized stimulus-esponsive dissolvable peg-hydrogels |
| 08/14/2013 | CN103243114A Fusion gene, protein expressed by same and application thereof |
| 08/14/2013 | CN103242452A Method for amplifying lymphocytes by using interleukin 15 receptor segment-interleukin 2 compound |
| 08/14/2013 | CN103242444A Modulation of SIRP-alpha - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 08/14/2013 | CN102584952B Antigen conformation epitope mimic peptide of hepatitis C virus F protein and application thereof |
| 08/14/2013 | CN102382193B Fusion protein capable of inducing and activating cancer-targeted T cells, preparation method and use thereof |
| 08/14/2013 | CN101955543B Nerve growth factor bound with laminin, and coding gene and application thereof |
| 08/14/2013 | CN101952320B Material with immunogenicity |
| 08/14/2013 | CN101711278B T4 bacteriophage bound to a substrate |
| 08/13/2013 | US8507426 Peptides and related molecules that bind to TALL-1 |
| 08/13/2013 | US8506964 Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| 08/13/2013 | US8506958 Methods for treating TWEAK-related conditions |
| 08/13/2013 | CA2587092C A method of expressing small peptides using cereal non-storage proteins as fusion carrier in endosperm and the use thereof |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/13/2013 | CA2469151C Immunocytokines with modulated selectivity |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2413003C Immunoassays for anti-hcv antibodies |
| 08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 08/08/2013 | WO2013116764A1 Synthetic chloroplast transit peptides |
| 08/08/2013 | WO2013116758A1 Synthetic brassica-derived chloroplast transit peptides |
| 08/08/2013 | WO2013116731A1 Plant transactivation interaction motifs and uses thereof |
| 08/08/2013 | WO2013115926A2 Aspartyl-trna synthetase-fc conjugates |
| 08/08/2013 | US20130203964 Antibody derivatives |
| 08/08/2013 | US20130203961 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 08/08/2013 | US20130203675 Asymmetric biofunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents |
| 08/08/2013 | US20130203119 Nucleic acid modifying enzymes |
| 08/08/2013 | US20130203101 Method and system for purifying and quantitating proteins using heme fusion tags |
| 08/08/2013 | US20130203098 Enzyme Sensors, Methods for Preparing and Using Such Sensors, and Methods of Detecting Protease Activity |
| 08/08/2013 | US20130202552 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 08/07/2013 | EP2623512A1 Peptide capable of binding to immunoglobulin |
| 08/07/2013 | EP2621957A2 Chimeric spider silk and uses thereof |
| 08/07/2013 | EP2621945A2 Nd2 peptides and methods of treating neurological disease |
| 08/07/2013 | CN103237806A Peptide capable of binding to immunoglobulin |
| 08/07/2013 | CN103233022A Preparation method of bacillus thuringiensis crystal fusion protein Bt Cry9C |
| 08/07/2013 | CN103233021A Preparation method of bacillus thuringiensis crystal fusion protein Bt Cry35Ba2 |
| 08/07/2013 | CN103233020A A preparation method for a crystal fusion protein Cry34B of Bacillus thuringiensis |
| 08/07/2013 | CN103232545A Recombination porcine interferon alpha1-Fc fusion protein as well as coding gene and expression method thereof |
| 08/07/2013 | CN103232544A Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof |
| 08/07/2013 | CN103232543A Recombinant protein Tumstatin-CD137L4 with Tumstatin activities as well as preparation method and application thereof |